264 filings
Page 10 of 14
8-K
by3suke
18 Mar 20
Other Events
8:04am
8-K
31r2iky7s j5wal
17 Mar 20
Other Events
8:23am
4
b1jyjlz
16 Mar 20
Eton Pharmaceuticals / MARK L BAUM ownership change
4:58pm
4
9gktegn0uthgul
16 Mar 20
Eton Pharmaceuticals / William Wilson Troutman ownership change
4:56pm
4
5randt1n162gs
16 Mar 20
Eton Pharmaceuticals / CHARLES J CASAMENTO ownership change
4:56pm
4
1vrpjvweumb6iyl be
16 Mar 20
Eton Pharmaceuticals / PAUL V MAIER ownership change
4:54pm
4
rlowlb
16 Mar 20
Eton Pharmaceuticals / NORBERT G RIEDEL ownership change
4:52pm
4
krl54 h9mkj
16 Mar 20
Eton Pharmaceuticals / SEAN BRYNJELSEN ownership change
4:52pm
8-K
m9dlsto
6 Mar 20
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results
7:37am
8-K
e2x08zlnnvpx0ufs
19 Feb 20
Eton Pharmaceuticals Provides Update on ET-105 Program
8:30am
SC 13G/A
y31 9llno8cm
14 Feb 20
Beneficial ownership report (amended)
12:00am
SC 13G/A
codlghw7 ribz15ggo
4 Feb 20
Beneficial ownership report (amended)
4:51pm
8-K
fnxti5dm5ip8
21 Jan 20
Eton Pharmaceuticals and Xellia Pharmaceuticals Announce Biorphen® (phenylephrine HCl) Co-Promotion Agreement
7:52am
EFFECT
0bnaqa6qq38wc
17 Dec 19
Notice of effectiveness
12:15am
8-K
438dbktk
12 Dec 19
Other Events
7:41am
CORRESP
88vzos
12 Dec 19
Correspondence with SEC
12:00am
UPLOAD
lhzx8c721p
10 Dec 19
Letter from SEC
12:00am
8-K
opngr
3 Dec 19
Eton Pharmaceuticals Announces Commercial Availability of Biorphen® (phenylephrine HCI) Injection
7:39am
S-3
hpq2x13drllajm2qd3hy
2 Dec 19
Shelf registration
5:04pm